GE Enhances Workflow in Echo Lab, OR and Cath Lab with Vivid E9 Cardiovascular Ultrasound

2 mins read

The FINANCIAL — GE Healthcare, a unit of General Electric Company announced the FDA clearance and availability of the latest version of its Vivid E9 cardiovascular ultrasound system.

 

According to General Electric Company, the Vivid E9 Breakthrough 2012 (BT12) includes a 4D transducer for transesophageal echocardiography (TEE), and also provides innovative tools designed to help improve workflow efficiency through simplified image acquisition, intuitive navigation and advanced, yet easy to use quantification.

While Vivid E9 is currently used most frequently in the echo lab, the availability of the 4D TEE transducer enables the system to be used more often in settings including the cath lab, and the operating room. The TEE transducer will allow clinicians to view precise images of the heart during assessment/diagnosis performed in the echo lab, and to support invasive surgical procedures in the operating room, as well as image-guided procedures in the cath lab. With the TEE transducer, Vivid E9 can now be leveraged for procedures including mitral valve repair, transcatheter aortic valve repair (TAVR/TAVI), atrial septal defect (ASD) closures and patent foraman ovale (PFO) closures.

“With a recent increase in TEE procedures, our customers in the cath lab, echo lab and operating room have been looking for ways to achieve the benefits of 4D imaging without compromising productivity,” said Al Lojewski, General Manager of Cardiovascular Ultrasound at GE Healthcare. “Our Vivid E9 system was designed to help make 4D imaging easier and more efficient. With the new 4D TEE transducer as well as several important workflow enhancements, this latest version of Vivid E9 underscores our commitment to making 4D imaging accessible and efficient across the continuum of care in cardiology.”

See also  Binance Connect Partners with Trust Wallet to Drive Crypto Adoption

“The new 4D transesophageal probe developed by GE Healthcare is an advanced diagnostic tool,” said Dr. Luigi P. Badano of the University of Padua, Padua, Italy. “It combines ease-of-use and flexibility to acquire 4D data sets, user-friendly navigation tools that allow users to quickly visualize the cardiac structure of interest, and effective quantification software to quantitate left ventricular pump function, myocardial deformation and mitral valve morphology.”

The Vivid E9 BT12 also includes several features that are new to cardiovascular ultrasound, and which are designed to enhance 4D imaging and workflow. These include the industry’s first configurable TEE transducer, a new tilt and rotate function, and a live “2-Click Crop” tool. Workflow enhancements can also be achieved during mitral valve acquisition with a dedicated MV button and during quantification with a new plug-in tool that has the potential to decrease assessment time.

“Vivid E9 BT12 with the new 4D TEE probe has worked great, especially during our intense first two days of MitraClipTM procedures,” said Prof. Reidar Winter of the Karolinska University Hospital Stockholm, Sweden. “The system has tools like Biplane Prepare, Biplane Tilt/Rotate and Laser Lines that help optimize guidance of the catheter septal puncture as well as the mitral clip positioning, which has the potential to reduce procedure time.”

Vivid E9 BT12 is also CE Marked and available for sale across Europe and many countries around the world.

 

 

Leave a Reply